Compile Data Set for Download or QSAR
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 2382
TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363753(US9855229, Compound 7)
Affinity DataIC50: 0.615nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363754(US9855229, Compound 8)
Affinity DataIC50: 1.98nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363752(US9855229, Compound 6)
Affinity DataIC50: 2.18nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363747(US9855229, Compound 1)
Affinity DataIC50: 4.26nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363749(US9855229, Compound 3)
Affinity DataIC50: 5.52nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363750(US9855229, Compound 4)
Affinity DataIC50: 5.99nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363756(US9855229, Compound 10)
Affinity DataIC50: 16.2nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363751(US9855229, Compound 5)
Affinity DataIC50: 17.4nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363755(US9855229, Compound 9)
Affinity DataIC50: 18.4nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363748(US9855229, Compound 2)
Affinity DataIC50: 22.4nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Glenmark Pharmaceuticals

US Patent
LigandPNGBDBM363757(US9855229, Compound 11)
Affinity DataIC50: 25.7nMAssay Description:The assay is based on the principle that binding of the agonist to the RORγ causes a conformational change around helix 12 in the ligand binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2019
Entry Details
Go to US Patent